HCV-话题@MedSci

#HCV#

247篇内容 | 3055人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257742, encodeId=43ba125e742ad, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterol Hepatol：采用无干扰素治疗方案治疗1天后，患者血清HCV-RNA水平降低的临床意义, objectType=article, longId=140487, objectId=f2af14048ea5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2af14048ea5, replyNumber=0, likeNumber=30, createdTime=2018-06-12, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2af14048ea5, moduleTitle=J Gastroenterol Hepatol：采用无干扰素治疗方案治疗1天后，患者血清HCV-RNA水平降低的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2af14048ea5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257741, encodeId=40ee125e741a4, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterol Hepatol：HCV病毒的根除可以逆转胰岛素耐受并改善血糖控制, objectType=article, longId=140406, objectId=f3ed14040623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ed14040623, replyNumber=0, likeNumber=37, createdTime=2018-06-11, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ed14040623, moduleTitle=J Gastroenterol Hepatol：HCV病毒的根除可以逆转胰岛素耐受并改善血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ed14040623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257740, encodeId=af5b125e740ee, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Liver Int：采用DAA治疗HCV患者，获得SVR后，晚期肝纤维化和肝硬化患者的随访结果, objectType=article, longId=140301, objectId=8e3114030128, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e3114030128, replyNumber=0, likeNumber=40, createdTime=2018-06-09, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e3114030128, moduleTitle=Liver Int：采用DAA治疗HCV患者，获得SVR后，晚期肝纤维化和肝硬化患者的随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e3114030128)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257739, encodeId=17fd125e73970, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：在荷兰，近期开始采用的DAA治疗方案，对HCV基因1b型患者，治疗较好；但对HCV基因3型患者，疗效较差, objectType=article, longId=140112, objectId=29041401126d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29041401126d, replyNumber=0, likeNumber=49, createdTime=2018-06-07, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29041401126d, moduleTitle=J Viral Hepat：在荷兰，近期开始采用的DAA治疗方案，对HCV基因1b型患者，治疗较好；但对HCV基因3型患者，疗效较差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29041401126d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257738, encodeId=4f99125e73875, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterol Hepatol：HCV、HBV双感染阻断了血小板计数的恢复，尤其是在晚期肝纤维化患者中, objectType=article, longId=138360, objectId=810b138360f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=810b138360f6, replyNumber=0, likeNumber=35, createdTime=2018-05-18, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=810b138360f6, moduleTitle=J Gastroenterol Hepatol：HCV、HBV双感染阻断了血小板计数的恢复，尤其是在晚期肝纤维化患者中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=810b138360f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257737, encodeId=af7d125e737d6, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Liver Int：对采用以daclatasvir为基础治疗方案的HCV患者，进行长期随访, objectType=article, longId=138252, objectId=d2e11382522b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2e11382522b, replyNumber=0, likeNumber=41, createdTime=2018-05-17, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2e11382522b, moduleTitle=Liver Int：对采用以daclatasvir为基础治疗方案的HCV患者，进行长期随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2e11382522b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257736, encodeId=bd3d125e7369b, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险, objectType=article, longId=138064, objectId=bdd0138064e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdd0138064e2, replyNumber=0, likeNumber=24, createdTime=2018-05-15, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdd0138064e2, moduleTitle=Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdd0138064e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257735, encodeId=c3c4125e7353d, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：采用瞬时弹性成像评估HCV患者预后, objectType=article, longId=137953, objectId=abc513e953df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abc513e953df, replyNumber=0, likeNumber=40, createdTime=2018-05-13, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abc513e953df, moduleTitle=J Viral Hepat：采用瞬时弹性成像评估HCV患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abc513e953df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257734, encodeId=6e0d125e734a9, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=GUT：HCV患者实现SVR后肝外疾病风险显著降低, objectType=article, longId=137011, objectId=844e13e0110d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=844e13e0110d, replyNumber=0, likeNumber=37, createdTime=2018-05-04, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=844e13e0110d, moduleTitle=GUT：HCV患者实现SVR后肝外疾病风险显著降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=844e13e0110d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257733, encodeId=a0fc125e733a0, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatol Res：HCV患者采用直接抗病毒药物治疗，肝脏功能和身体组成的变化, objectType=article, longId=136281, objectId=1194136281a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1194136281a9, replyNumber=0, likeNumber=48, createdTime=2018-04-25, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1194136281a9, moduleTitle=Hepatol Res：HCV患者采用直接抗病毒药物治疗，肝脏功能和身体组成的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1194136281a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257732, encodeId=c331125e73283, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=GUT：哈维尼（ledipasvir/sofosbuvir）可有效治疗HCV4型感染人群, objectType=article, longId=136204, objectId=190f136204aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=190f136204aa, replyNumber=0, likeNumber=30, createdTime=2018-04-25, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=190f136204aa, moduleTitle=GUT：哈维尼（ledipasvir/sofosbuvir）可有效治疗HCV4型感染人群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=190f136204aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257731, encodeId=ff20125e7313c, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=BMC Infect Dis：瞬时弹性成像用于评估存在肝硬化的HIV/HCV共感染患者疾病预后，是无效的, objectType=article, longId=136091, objectId=50051360910e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50051360910e, replyNumber=0, likeNumber=38, createdTime=2018-04-23, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50051360910e, moduleTitle=BMC Infect Dis：瞬时弹性成像用于评估存在肝硬化的HIV/HCV共感染患者疾病预后，是无效的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50051360910e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257730, encodeId=d909125e7301a, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Liver Int：ombitasvir, paritaprevir/r+dasabuvir+ribavirin治疗HCV基因1b型肝硬化患者的真实疗效和安全性, objectType=article, longId=135698, objectId=b97d1356989d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b97d1356989d, replyNumber=0, likeNumber=23, createdTime=2018-04-19, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b97d1356989d, moduleTitle=Liver Int：ombitasvir, paritaprevir/r+dasabuvir+ribavirin治疗HCV基因1b型肝硬化患者的真实疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b97d1356989d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257729, encodeId=7645125e729d5, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：采用直接抗病毒药物清除HCV后，肝周淋巴结肿大消失, objectType=article, longId=135561, objectId=bcbf1355614d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcbf1355614d, replyNumber=0, likeNumber=36, createdTime=2018-04-18, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcbf1355614d, moduleTitle=J Viral Hepat：采用直接抗病毒药物清除HCV后，肝周淋巴结肿大消失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcbf1355614d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257728, encodeId=0511125e7284e, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：HCV直接抗病毒治疗后，血管生成素-2水平增加是肝癌复发和新发肝癌的预测因子, objectType=article, longId=134584, objectId=a694134584fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a694134584fd, replyNumber=0, likeNumber=29, createdTime=2018-04-10, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a694134584fd, moduleTitle=Hepatology：HCV直接抗病毒治疗后，血管生成素-2水平增加是肝癌复发和新发肝癌的预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a694134584fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257727, encodeId=e1a0125e727e4, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：接受DAA治疗的HCV晚期患者，新发HCC比率不高，可能是先前显微、未发现的肿瘤, objectType=article, longId=133476, objectId=28c81334e64c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28c81334e64c, replyNumber=0, likeNumber=37, createdTime=2018-03-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28c81334e64c, moduleTitle=J Hepatol：接受DAA治疗的HCV晚期患者，新发HCC比率不高，可能是先前显微、未发现的肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28c81334e64c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257726, encodeId=81b8125e72673, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：HCV患者接受直接抗病毒治疗获得SVR后，肝脏测试的持续变化并不少见, objectType=article, longId=132927, objectId=23e913292e7d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23e913292e7d, replyNumber=0, likeNumber=31, createdTime=2018-03-21, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23e913292e7d, moduleTitle=J Viral Hepat：HCV患者接受直接抗病毒治疗获得SVR后，肝脏测试的持续变化并不少见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23e913292e7d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257725, encodeId=f400125e72539, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：EBR/GZR联合SOF治疗HCV基因3型代偿性肝硬化患者初治和经治患者疗效良好, objectType=article, longId=132753, objectId=3721132e538f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3721132e538f, replyNumber=0, likeNumber=33, createdTime=2018-03-19, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3721132e538f, moduleTitle=Hepatology：EBR/GZR联合SOF治疗HCV基因3型代偿性肝硬化患者初治和经治患者疗效良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3721132e538f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257724, encodeId=77be125e724e0, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=South Med J：先天性心脏病患者中HCV的流行率和直接抗病毒治疗的效果, objectType=article, longId=132041, objectId=b1db13204187, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1db13204187, replyNumber=0, likeNumber=41, createdTime=2018-03-12, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1db13204187, moduleTitle=South Med J：先天性心脏病患者中HCV的流行率和直接抗病毒治疗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1db13204187)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257723, encodeId=0541125e72393, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：直接抗病毒药物治疗导致HCV清除后，可改善患者颈动脉粥样硬化, objectType=article, longId=131891, objectId=505213189132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=505213189132, replyNumber=0, likeNumber=35, createdTime=2018-03-10, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=505213189132, moduleTitle=J Hepatol：直接抗病毒药物治疗导致HCV清除后，可改善患者颈动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=505213189132)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HCV

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterol Hepatol：采用无干扰素治疗方案治疗1天后，患者血清HCV-RNA水平降低的临床意义

2018-06-12

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterol Hepatol：HCV病毒的根除可以逆转胰岛素耐受并改善血糖控制

2018-06-11

ymljack (审核中...)

前往app查看评论内容

#HCV#

Liver Int：采用DAA治疗HCV患者，获得SVR后，晚期肝纤维化和肝硬化患者的随访结果

2018-06-09

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：在荷兰，近期开始采用的DAA治疗方案，对HCV基因1b型患者，治疗较好；但对HCV基因3型患者，疗效较差

2018-06-07

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterol Hepatol：HCV、HBV双感染阻断了血小板计数的恢复，尤其是在晚期肝纤维化患者中

2018-05-18

ymljack (审核中...)

前往app查看评论内容

#HCV#

Liver Int：对采用以daclatasvir为基础治疗方案的HCV患者，进行长期随访

2018-05-17

ymljack (审核中...)

前往app查看评论内容

#HCV#

Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险

2018-05-15

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：采用瞬时弹性成像评估HCV患者预后

2018-05-13

ymljack (审核中...)

前往app查看评论内容

#HCV#

GUT：HCV患者实现SVR后肝外疾病风险显著降低

2018-05-04

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatol Res：HCV患者采用直接抗病毒药物治疗，肝脏功能和身体组成的变化

2018-04-25

ymljack (审核中...)

前往app查看评论内容

#HCV#

GUT：哈维尼（ledipasvir/sofosbuvir）可有效治疗HCV4型感染人群

2018-04-25

ymljack (审核中...)

前往app查看评论内容

#HCV#

BMC Infect Dis：瞬时弹性成像用于评估存在肝硬化的HIV/HCV共感染患者疾病预后，是无效的

2018-04-23

ymljack (审核中...)

前往app查看评论内容

#HCV#

Liver Int：ombitasvir, paritaprevir/r+dasabuvir+ribavirin治疗HCV基因1b型肝硬化患者的真实疗效和安全性

2018-04-19

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：采用直接抗病毒药物清除HCV后，肝周淋巴结肿大消失

2018-04-18

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：HCV直接抗病毒治疗后，血管生成素-2水平增加是肝癌复发和新发肝癌的预测因子

2018-04-10

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：接受DAA治疗的HCV晚期患者，新发HCC比率不高，可能是先前显微、未发现的肿瘤

2018-03-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：HCV患者接受直接抗病毒治疗获得SVR后，肝脏测试的持续变化并不少见

2018-03-21

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：EBR/GZR联合SOF治疗HCV基因3型代偿性肝硬化患者初治和经治患者疗效良好

2018-03-19

ymljack (审核中...)

前往app查看评论内容

#HCV#

South Med J：先天性心脏病患者中HCV的流行率和直接抗病毒治疗的效果

2018-03-12

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：直接抗病毒药物治疗导致HCV清除后，可改善患者颈动脉粥样硬化

2018-03-10

科室
- - 订阅+
  - 更多科室
工具
服务